It marks the second COVID-19 vaccine green-lighted for public use in China, after a shot developed by a Beijing institute affiliated to the state-owned China National Pharmaceutical Group (Sinopharm) was approved in December. https://new.globalreports.com/manage/article?ref=utbmkv#